Assessment of myocardial area at risk by technetium-99m sestamibi during coronary artery occlusion: comparison between three tomographic methods of quantification

European Journal of Nuclear Medicine
L CerianiG L Tarolo

Abstract

The aim of this study was to directly compare three currently used quantitative methods of analysis of technetium-99m sestamibi images in patients with selective balloon-induced transmural ischaemia. The area at risk (AR) was assessed in 19 patients undergoing single-vessel percutaneous transluminal coronary angioplasty by injecting the 99mTc-sestamibi at the time of coronary artery occlusion during balloon inflation. After imaging, the patients were classified according to localization of the perfusion defect as having anteroseptal (group I, 11 patients) or posterolateral defects (group II, eight patients). The planimetric technique based on polar maps, proposed by Verani et al. (J Am Coll Cardiol, 1988) (method A), the method described by Tamaki et al. (Circulation, 1982) (method B) and the technique validated by O Connor et al. (Eur J Nucl Med, 1990) (method C) were tested. Three threshold values of 45%, 50% and 60% of the maximum left ventricular count were used to define the limits of the perfusion defect. The mean values of the AR calculated by the three techniques with the original cut-off level (method A=16.5%+/-12.9; method B=10.4%+/-7.6%; method C=29.6%+/-15.7%) were statistically different (one-way analysis of varian...Continue Reading

References

Jan 1, 1992·Journal of the American College of Cardiology·K C HuberR J Gibbons
Dec 1, 1989·Journal of the American College of Cardiology·V DilsizianC A Boucher
Apr 1, 1988·Journal of the American College of Cardiology·J L RitchieJ W Kennedy
Mar 1, 1987·Journal of the American College of Cardiology·G A Beller

❮ Previous
Next ❯

Citations

Nov 13, 2012·Journal of Nuclear Cardiology : Official Publication of the American Society of Nuclear Cardiology·José F Rodríguez-PalomaresDavid García-Dorado
May 7, 2015·European Heart Journal Cardiovascular Imaging·Anders ThomassenPoul Flemming Høilund-Carlsen
Mar 6, 2002·Circulation·Hitoshi MatsuoHisayoshi Fujiwara
Sep 27, 2005·European Heart Journal·Osvaldo Pereztol-ValdésJordi Soler-Soler

❮ Previous
Next ❯

Related Concepts

Related Feeds

Cardiomyopathy

Cardiomyopathy is a disease of the heart muscle, that can lead to muscular or electrical dysfunction of the heart. It is often an irreversible disease that is associated with a poor prognosis. There are different causes and classifications of cardiomyopathies. Here are the latest discoveries pertaining to this disease.